Hypersensitivity Pneumonitis (HP) Care by Advanced Practice Providers
Discover a dedicated network for Interstitial Lung Disease. We empower individuals and organizations to advance ILD care and research. Join
The care of advanced practice providers in hypersensitivity pneumonitis (HP) involves detailed exposure assessment, precise diagnostic undertakings, comprehensive management, and established longitudinal observations HP (Hypersensitivity Pneumonitis) is an immune mediated interstitial lung disease caused by exposure to environmental antigens that include mold, bird's and agricultural dusts, and other work place exposures.
Care of HP involves advanced practice providers, identifying triggering exposures, guiding high resolution CT, pulmonary function test interpretation, and other therapy initiation and facilitating antigen avoidance programs. HP has acute, subacute, or chronic fibrotic disease presentations which underscores the importance of APPs in assessing and diagnosing inflammatory versus progressive fibrotic types.
Advanced Practice Providers (APPs) have the opportunity to enhance their capabilities in comprehensive HP management through case-based learning, the ILD Community Network (ICN) APP educational materials, and expert case collaborations.
HP management by APPs is focused on determining exposure, accurate HP diagnosis, timely therapy initiation, and effective monitoring of disease progression. When combined with the environmental evaluation, multidisciplinary collaboration, and active management of disease, APPs have the greatest impact on patient symptoms and disease progression.
With the professional contacts, digital learning modules, and the ILD Community Network, and APPs clinical updates, HP care and management can be undertaken with confidence and in accordance with the current best practices.
